Universidade Estadual Paulista Júlio de Mesquita Filho
Quick facts
Marketed products
- Chlorhexidine rinse · Oral health / Dentistry
Chlorhexidine rinse works by disrupting bacterial cell membranes and precipitating bacterial proteins, providing broad-spectrum antimicrobial activity in the oral cavity. - General anesthesia · Anesthesiology
General anesthesia depresses the central nervous system to produce unconsciousness, analgesia, and muscle relaxation for surgical procedures.
Phase 3 pipeline
- Lactobacillus reuteri Oral Drops · Gastroenterology / Immunology
Lactobacillus reuteri is a probiotic bacterium that modulates the gut microbiota and immune system to promote health and prevent disease.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Universidade Estadual Paulista Júlio de Mesquita Filho portfolio CI brief
- Universidade Estadual Paulista Júlio de Mesquita Filho pipeline updates RSS
Frequently asked questions about Universidade Estadual Paulista Júlio de Mesquita Filho
What are Universidade Estadual Paulista Júlio de Mesquita Filho's marketed drugs?
Top marketed products include Chlorhexidine rinse, General anesthesia.
What is Universidade Estadual Paulista Júlio de Mesquita Filho's pipeline?
Universidade Estadual Paulista Júlio de Mesquita Filho has 1 drugs in Phase 3, 0 in Phase 2, 1 in Phase 1. Late-stage candidates include Lactobacillus reuteri Oral Drops.
Related
- Chlorhexidine rinse · Oral health / Dentistry
- General anesthesia · Anesthesiology
- Sector hub: All tracked pharma companies